Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931644 · ClinicalTrials.gov registry record
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
A clinical trial, sponsored by Sanguine Biosciences.
- Completed
- Registry status
- 17,667
- Enrollment target
NCT01931644: Completed study, sponsored by Sanguine Biosciences.
NCT01931644 is a clinical trial that has completed, run by Sanguine Biosciences. The registered enrollment target is 17,667 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01931644 has completed, sponsored by Sanguine Biosciences.
- COMPLETED
- Registry status
- 17,667 participants
- Enrollment target
Study Summary
We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location or ability to travel.
Primary Outcome
To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,667 participants |
| Start Date | 2013-07 |
| Est. Completion | 2024-04 |
What the finished NCT01931644 record still lists
NCT01931644 is an observational study that tracks outcomes without assigning an intervention. Its 17,667 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01931644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01931644 about?
NCT01931644 is a clinical study titled "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions". We are the missing link in clinical trials, connecting patients and researchers seamlessly and conveniently using a mobile health platform to advance medical research. We make it easy for patients to contribute to research for medical conditions that matter most to them, regardless of their location...
What is the current status of trial NCT01931644?
This trial is currently completed. The enrollment target is 17,667 participants. The study started on 2013-07. Estimated completion is 2024-04.
Who is sponsoring clinical trial NCT01931644?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT04110522 · 18,000 participants · NA
Psoriatic Arthritis D2P Screening
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia